Renal risk stratification in left ventricular assist device therapy

Area of Science:

• Cardiology
• Nephrology
• Medical Devices

Background:

• Left ventricular assist device (LVAD) therapy significantly reduces mortality in advanced heart failure (HF).
• LVAD recipients face risks of renal dysfunction, complicating management and increasing adverse outcomes.
• Renal dysfunction can stem from residual HF effects or LVAD support itself.

Purpose of the Study:

• To summarize predictors of post-LVAD renal dysfunction and need for renal replacement therapy (RRT).
• To discuss dynamic changes in renal function post-LVAD.
• To highlight challenges in managing LVAD patients requiring chronic RRT.

Main Methods:

• Review of current understanding of pre-LVAD predictors of renal dysfunction.
• Inclusion of emerging data on proteinuria as a risk factor.
• Discussion of perioperative hemodynamic management and RRT management.

Main Results:

• Pre-LVAD proteinuria and reduced renal function are significant predictors of RRT.
• Requirement for RRT before or after LVAD placement indicates a high mortality risk.
• Identifying high-risk patients for post-LVAD RRT is crucial.

Conclusions:

• Proteinuria and impaired renal function prior to LVAD implantation are key indicators for RRT.
• Risk assessment for LVAD therapy must include evaluation of renal function and proteinuria.
• Proactive management strategies are needed for LVAD patients at risk of renal dysfunction.